BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3428478)

  • 21. Vitamin K1 2,3-epoxide and quinone reduction: mechanism and inhibition.
    Preusch PC; Smalley DM
    Free Radic Res Commun; 1990; 8(4-6):401-15. PubMed ID: 2113031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of warfarin resistance and liver microsomal vitamin K epoxide reductase activity in rats.
    MacNicoll AD
    Biochim Biophys Acta; 1985 May; 840(1):13-20. PubMed ID: 3995080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is thioredoxin the physiological vitamin K epoxide reducing agent?
    Preusch PC
    FEBS Lett; 1992 Jul; 305(3):257-9. PubMed ID: 1299627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal variation in the effects of warfarin on the vitamin K cycle.
    Soulban G; Labrecque G; BĂ©langer PM
    Chronobiol Int; 1990; 7(5-6):403-11. PubMed ID: 2097073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin K epoxide and quinone reductase activities. Evidence for reduction by a common enzyme.
    Gardill SL; Suttie JW
    Biochem Pharmacol; 1990 Sep; 40(5):1055-61. PubMed ID: 2390102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of vitamin K1 2,3-epoxide in rat liver mitochondria.
    Inyangetor PT; Thierry-Palmer M
    Arch Biochem Biophys; 1988 May; 262(2):389-96. PubMed ID: 2835004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conversion of vitamin K epoxide to hydroxyvitamin K by liver microsomes from warfarin-resistant rats.
    Nutr Rev; 1983 Aug; 41(8):253-4. PubMed ID: 6355923
    [No Abstract]   [Full Text] [Related]  

  • 28. Lapachol inhibition of vitamin K epoxide reductase and vitamin K quinone reductase.
    Preusch PC; Suttie JW
    Arch Biochem Biophys; 1984 Nov; 234(2):405-12. PubMed ID: 6497379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural prenylquinones inhibit the enzymes of the vitamin K cycle in vitro.
    Ronden JE; Soute BA; Thijssen HH; Saupe J; Vermeer C
    Biochim Biophys Acta; 1996 Nov; 1298(1):87-94. PubMed ID: 8948492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formation of hydroxyvitamin K by vitamin K epoxide reductase of warfarin-resistant rats.
    Fasco MJ; Preusch PC; Hildebrandt E; Suttie JW
    J Biol Chem; 1983 Apr; 258(7):4372-80. PubMed ID: 6833262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulfaquinoxaline inhibition of vitamin K epoxide and quinone reductase.
    Preusch PC; Hazelett SE; Lemasters KK
    Arch Biochem Biophys; 1989 Feb; 269(1):18-24. PubMed ID: 2916837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reduction.
    Lee JJ; Principe LM; Fasco MJ
    Biochemistry; 1985 Dec; 24(25):7063-70. PubMed ID: 4084561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microsomal warfarin binding and vitamin K 2,3-epoxide reductase.
    Thijssen HH; Baars LG
    Biochem Pharmacol; 1989 Apr; 38(7):1115-20. PubMed ID: 2706010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Warfarin poisoning and vitamin K antagonism in rat and human liver. Design of a system in vitro that mimics the situation in vivo.
    Wallin R; Martin LF
    Biochem J; 1987 Jan; 241(2):389-96. PubMed ID: 3593198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin K antagonism of coumarin intoxication in the rat.
    Wallin R; Patrick SD; Ballard JO
    Thromb Haemost; 1986 Apr; 55(2):235-9. PubMed ID: 2424118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue distribution and warfarin sensitivity of vitamin K epoxide reductase.
    Hazelett SE; Preusch PC
    Biochem Pharmacol; 1988 Mar; 37(5):929-34. PubMed ID: 3345202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B16 tumor cells contain a warfarin sensitive vitamin K1 2,3 epoxide reductase.
    Uitendaal MP; Thijssen HH; Drittij-Reijnders MJ; Hoeijmakers MJ
    Biochem Biophys Res Commun; 1986 Jun; 137(3):1015-20. PubMed ID: 3729947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disulfide-dependent protein folding is linked to operation of the vitamin K cycle in the endoplasmic reticulum. A protein disulfide isomerase-VKORC1 redox enzyme complex appears to be responsible for vitamin K1 2,3-epoxide reduction.
    Wajih N; Hutson SM; Wallin R
    J Biol Chem; 2007 Jan; 282(4):2626-35. PubMed ID: 17124179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depression of liver microsomal vitamin K epoxide reductase activity associated with antibiotic-induced coagulopathy.
    Matsubara T; Touchi A; Harauchi T; Takano K; Yoshizaki T
    Biochem Pharmacol; 1989 Aug; 38(16):2693-701. PubMed ID: 2764989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro effect of beta-lactam antibiotics and N-methyltetrazolethiol on microsomal vitamin K epoxide reductase in rats.
    Kawamoto K; Touchi A; Sugeno K; Matsubara T
    Jpn J Pharmacol; 1988 Jun; 47(2):169-78. PubMed ID: 3199593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.